Viking Therapeutics
VKTX
VKTX
143 hedge funds and large institutions have $212M invested in Viking Therapeutics in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 50 reducing their positions, and 17 closing their positions.
Holders
143
Holders Change
+3
Holders Change %
+2.14%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
44
Reduced
50
Closed
17
Calls
$4.78M
Puts
$2.87M
Net Calls
+$1.91M
Net Calls Change
-$3.6M
Top Buyers
| 1 |
1
BlackRock
New York
|
$29.9M |
| 2 |
ACH
2
ArrowMark Colorado Holdings
Denver,
Colorado
|
$47.9M |
| 3 |
3
Two Sigma Advisers
New York
|
$2.61M |
| 4 |
4
Two Sigma Investments
New York
|
$1.63M |
| 5 |
5
Group One Trading
Chicago,
Illinois
|
$1.84M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$438K |
| 2 |
DM
2
Deerfield Management
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$485K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$478K |
| 5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.75M |
